期刊文献+

氟尿嘧啶及顺铂对胃癌细胞microRNAs 表达谱的影响

5-Fluorouraeil and cisplatin modify expression profiles of microRNAs in human gastric cancer cells in vitro
下载PDF
导出
摘要 目的通过分析氟尿嘧啶(5-Fu)联合顺铂(DDP)对胃癌细胞 microRNAs 表达谱的影响,探讨其治疗的分子机制.方法 MTT 法检测不同浓度5-Fu(终浓度分别为80、40、20、10、5、2.5μg/ml)和 DDP (终浓度分别为1.6、0.8、0.4、0.2、0.1、0.05μg/ml)作用下人胃癌细胞株9811P 增殖情况;用 IC50浓度的5-Fu和 DDP 干预9811P 细胞48h 后,利用 miRNA 芯片检测用药前后9811P 细胞 miRNAs 表达的差异;并用实时定量 RT-PCR 进行验证.结果5-Fu及 DDP 与人胃癌细胞株9811P 生长抑制率之间有浓度依赖关系,48h 的 IC50值分别为7.68、0.59μg/ml;分别用 IC50浓度的5-Fu和 DDP 干预细胞48h 后筛到29个与5-Fu干预相关 miRNAs,27个与 DDP 干预相关 miRNAs,应用实时定量 PCR 来验证了5-Fu和 DDP 组均显著上调的3个 miRNAs (miR-31、miR-96和 miR-141),结果与芯片结果一致.通过 TargetScan 等软件对 miR-96靶基因进行预测,共筛选出8个靶基因的生物学功能与胃癌相关.结论5-Fu和顺铂对胃癌细胞 miRNAs 的表达谱有影响,可能是5-Fu 和顺铂抑制胃癌细胞生长的作用途径之一. Objective To investigate the effect of 5-fluorouracil (5-Fu) and cisplatin (DDP) on the expression profiles of miRNAs in human gastric cancer cel s. Methods The anti-tumor effect of 5-Fu and DDP on gastric cancer 9811P cel s was an-alyzed by MTT and IC50 values of both drugs were calculated. The differential expression of miRNAs were analyzed by miRNA mi-croarray, RT-PCR and verified by RT-PCR. Results IC50 values of 5-Fu and DDP for the 9811P cel s were 7.68μg/ml and 0.59μg/ml respectivelyt. Compared to controls 29 and 27 of miRNAs in gastric cancer 9811P cel s were identified as differential y expressed after exposed to 5-Fu or cisplatin, respectively. miR-31, miR-96, miR-141 were up-regulated in cel lines both after treatment of 5-Fu or DDP, which were validated by RT-PCR. Prediction of miR-96 with TargetScan software revealed that 8 genes might be related to biological behavior of gastric cancer. Conclusion 5-Fu and DDP can modify the expression profiles of miRNAs in gastric cancer cel s, which may be partial y associate with their pharmacological effects
出处 《浙江医学》 CAS 2012年第23期1871-1873,1904,共4页 Zhejiang Medical Journal
基金 浙江省卫生厅科研基金项目(2009A026)
关键词 氟尿嘧啶 顺铂 胃癌 MICRORNA Fluorouracil Cisplatin Gastric cancer MicroRNA
  • 相关文献

参考文献11

  • 1Li X,Zhang Y. Survival prediction of gastric can-cer by a seven-microRNA signature[J].Gut,2010.579-585.
  • 2Zhang Y,Guo J,Li D. Down-regulation of miR-31 ex-pression in gastric cancer tissues and its clinical significance[J].Medical Oncology,2010,(03):685-689.
  • 3Bandres E,Cubedo E,Agirre X. Identification by Real-time PCR of 13 mature microRNAs differential y expressed in col-orectal cancer and non-tumoral tissues[J].Molecular Cancer Therapeutics,2006.29.
  • 4Yan L X,Huang X F,Shao Q. MicroRNA miR-21 overexpres-sion in human breast cancer is associated with advanced clini-cal stage,lymph node metastasis and patient poor prognosis[J].RNA-A PUBLICATION OF THE RNA SOCIETY,2008.2348-2360.
  • 5Du Y,Xu Y,Ding L. Down-regulation of miR-141 in gastric cancer and its involvement in cel growth[J].Journal of Gastroenterology,2009.556-561.
  • 6Wong Q W,Lung R W,Law P T. MicroRNA-223 is commonly repressed in hepatocel ular carcinoma and potentiates expres-sion of Stathmin1[J].Gastroenterology,2008.257-269.
  • 7Schaefer A,Jung M,Mol enkopf H J. Diagnostic and prog-nostic implications of microRNA profiling in prostate carcinoma[J].International Journal of Cancer,2010.1166-1176.
  • 8Taylor D D,Gercel-Taylor C. MicroRNA signatures of tumor-de-rived exosomes as diagnostic biomarkers of ovarian cancer[J].Gynecologic Oncology,2008.13-21.
  • 9Zhang L,Deng T,Li X. microRNA-141 is involved in a na-sopharyngeal carcinoma-related genes network[J].Carcinogenesis,2010.559-566.
  • 10Yu S,Lu Z,Liu C. miRNA-96 suppresses KRAS and Func-tions as a tumor suppressor gene in pancreatic cancer[J].Can-cer Res,2010.6015-6025.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部